A number of drugs manufactured by drug companies and sold as blood thinners have one major side effect, and this is of particular importance to anyone considering a pharmaceutically developed drug that acts as a thinning medication. Anticoagulant drugs such as Xarelto can thin the blood to such a degree that slight internal bleeding can become difficult to stop. Internal hemorrhaging can continue unchecked unless emergency surgery is performed. When blood escapes from a small artery or capillary in or near a major organ, nutrient transport and cellular respiration is interrupted, sometimes leading to organ failure. Sometimes a blood clot can travel to another location and become trapped in an even smaller vessel, combining with other clots to form a total blockage of the artery or vein.
Unlike some other anticoagulant drugs currently on the market, Xarelto was not developed along with a specific antidote medication for internal hemorrhaging. This has caused widespread concern, and a growing number of individuals who have suffered internal bleeding thought to be caused by Xarelto have now filed complaints against Johnson & Johnson and Janssen Pharmaceuticals.
Those who take Xarelto and experience internal bleeding as a side effect are at risk for serious medical complications, particularly tissue damage to the organs. This can mean additional medical treatment, lost time from work and therefore a stoppage of income, expenses for traveling to out-of-town clinics, and even a rise in medical insurance premiums.
Wrongful death lawsuits have been filed and cases successfully won by plaintiffs who lay the blame directly on the drug manufacturer. These lawsuits are best handled by an experienced staff of attorneys who have a great deal of experience in medical malpractice claims. Because the drug companies have an enormous amount of at-risk capital with which to work, they maintain contractual agreements with their own team of defense attorneys and pay a lot of money for malpractice insurance.
Blood thinners are commonly prescribed as a means to reduce the chances of small blood clots forming. Persons diagnosed with medical conditions that include an increased risk of heart attack or stroke often take blood thinners such as aspirin. A number of pharmaceutically developed drugs are also available including Xarelto.
Xarelto is the brand name of the generic medication rivaroxaban, and it is manufactured and marketed by Janssen Pharmaceuticals. It was developed as a specialized blood thinning agent that works to prevent the forming of clots in the smaller arteries, veins, and capillaries. Xarelto was approved by the Food & Drug Administration in 2011 as a uniform-dose medication. Many consumers taking Xarelto have issued formal complaints to Janssen Pharmaceuticals and its parent company, Johnson & Johnson, stating various side effects that have proven dangerous to their health.
How Xarelto Works
Most blood thinning medications developed over the past few decades target specific conditions. One of the major risks associated with cardiovascular conditions is the likelihood of a clot forming in or around the heart and traveling to the brain. This is one of the major causes of stroke. Xarelto is in a class of drugs known as anti-thrombotics. These are substances that thin the blood and help prevent a clot from forming in a congested area of an artery or vein.
This type of medication is often prescribed for persons who have restricted blood flow due to a buildup of cholesterol. Clots may form in a small vessel in the heart or elsewhere because the blood flow is under heavier pressure in arteries, veins, or capillaries that have become clogged.
When clots begin to form, active agents in the blood perform chemical reactions that form an enzyme known as thrombin. Thrombin causes the protein fibrinogen to convert to another enzyme called fibrin. Fibrin bonds together blood platelets, and this completes the process of blood clot formation.
Xarelto combines with agents in the bloodstream to prevent the formation of fibrin. This keeps blood clots from forming in small vessels and traveling to the brain or other organs.